A Study of PTX-9908 Injection for Non-resectable HCC with TACE
Clinical trial NCT03812874 · RECRUITING
Trial details
- NCT number
- NCT03812874
- Sponsor
- TCM Biotech International Corp.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-06
- Primary completion
- 2026-08-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.